Why Nogin Shares Are Trading Higher By Around 77%; Here Are 20 Stocks Moving Premarket

Gainers

Ibio Inc IBIO shares rose 162.6% to $1.97 in pre-market trading after dropping around 12% on Thursday. JMP Securities, on Thursday, downgraded iBio from Market Outperform to Market Perform.
Nogin Inc NOGN rose 76.6% to $1.08 in pre-market trading after the company and Seychelles Imports LLC announced an agreement under which Sychelles will utilize Nogin's Customer Data Platform and Marketing Automation and Marketplace Dropship.
Universal Security Instruments, Inc. UUU rose 21.1% to $2.66 in pre-market trading after the company reported a year-over-year increase in Q3 EPS and revenues.
Meta Materials Inc MMAT rose 18.8% to $0.87 in pre-market trading after the company received new purchase order from its G10 central bank customer.
Heliogen Inc HLGN shares rose 13.5% to $0.41 in pre-market trading. Heliogen, in update letter to shareholders, said it hopes to create shareholder value necessary to regain NYSE compliance without need for reverse stock split.
Bark Inc BARK shares rose 10.2% to $1.73 in pre-market trading after gaining 8% on Thursday. BARK CFO Zahir Ibrahim acquired a total of 100,000 shares at an average price of $1.55.
Jasper Therapeutics Inc JSPR rose 7.7% to $1.97 in pre-market trading after the company reported follow-up clinical data from investigator-sponsored study of briquilimab conditioning in sickle cell disease patients.
VEON Ltd VEON rose 7.6% to $0.77 in pre-market trading after dropping around 9% on Thursday. Veon recently received Russian regulatory approval for the proposed sale of its Russian operations.
DoorDash Inc DASH rose 6.7% to $71.37 in pre-market trading after the company reported better-than-expected Q4 revenues and announced a $750 million buyback program.
Spectrum Pharmaceuticals, Inc. SPPI rose 4.6% to $0.86 in pre-market trading after declining around 7% on Thursday. Spectrum Pharmaceuticals recently received permanent J-Code for ROLVEDON injection (J1449) from US Centers For Medicare & Medicaid Services.

Losers

VolitionRX Ltd VNRX shares fell 18.4% to $1.66 in pre-market trading after the company reported a proposed underwritten public offering of common stock.
XP Inc XP shares dropped 13.1% to $13.82 in pre-market trading after the company reported a drop in Q4 net revenue.
Pop Culture Group Co Ltd CPOP fell 12% to $0.88 in pre-market trading.
Ambrx Biopharma Inc - ADR AMAM fell 11.5% to $2.46 in pre-market trading. Ambrx Biopharma shares jumped 56% on Thursday after the company announced initial data from its ongoing Phase 1 APEX-01 trial of ARX517, Ambrx's proprietary anti-PSMA ADC, in prostate cancer patients.
Stem Inc STEM fell 11.1% to $8.66 in pre-market after the company reported worse-than-expected Q4 results.
Axcella Health Inc AXLA fell 10.4% to $0.65 in pre-market trading. Axcella shares climbed over 19% on Thursday after the company announced FDA clearance of its IND application to initiate a phase 2b/3 trial in the U.S. for AXA1125.
Applied Therapeutics Inc APLT shares fell 10.3% to $1.05 in pre-market trading after gaining 17% on Thursday. Applied Therapeutics announced sorbitol reduction data from the ongoing global Phase 3 INSPIRE trial of oral AT-007 in approximately 50 patients with SORD Deficiency in the U.S. and Europe.
Nextplay Technologies Inc NXTP fell 9.5% to $2.00 in pre-market trading. NextPlay, last month, announced a 1-for-20 reverse stock split.
Boxed Inc BOXD fell 9.1% to $0.65 in pre-market trading after jumping 63% on Thursday.
Natwest Group PLC - ADR NWG fell 8.2% to $6.84 in pre-market trading. NatWest Group Q4 clocked a 42.5% year-over-year total income growth to £3.71 billion.